Media Releases

High hopes new drug could be a ‘game changer’ against long-incurable Alzheimer’s

September 1, 2016

The Star | August 31, 2016

One strength is that adu­canum­ab tar­gets a par­tic­u­lar­ly nasty vari­ety of amy­loid known as “oligomers,” accord­ing to Dr. San­dra Black, a neu­rol­o­gy pro­fes­sor with the Uni­ver­si­ty of Toron­to and Sun­ny­brook Health Sci­ences Cen­tre, which will serve as a clin­ic site for the antibody’s Phase 3 tri­als. Read more.